Full-Time

Sr. Manager

Data Architecture

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Data Management
Data Engineering
Data & Analytics
Required Skills
Microsoft Azure
Data Science
Machine Learning
AWS
Data Analysis
Google Cloud Platform
Requirements
  • Doctorate degree and 2 years of Information Systems experience OR
  • Master’s degree and 8 to 10 years of Information Systems experience OR
  • Bachelor’s degree and 10 to 14 years of Information Systems experience OR
  • Diploma and 14 to 18 years of Information Systems experience
  • 4 years of managerial experience directly managing people and leadership experience leading teams, projects, or programs.
  • Relevant experience in Pharma.
  • Soft and technical skills: In-depth knowledge of Pharma processes with preferred specialization in a domain (e.g., R&D, Commercial, finance, Operations, etc.)
  • 5+ years of experience in designing and implementing data architectures and data engineering.
  • Proven leadership skills with a track record of managing and mentoring hard-working data architecture teams.
  • Proven expertise in data architectures design for large organizations, data modeling, database design, and cloud platforms (AWS, Azure, GCP).
  • Experience with big data technologies and modern ETL/ELT frameworks.
  • Strong understanding of data governance, data security, and compliance standards.
  • Experience managing multi-functional teams and enterprise-wide data initiatives.
Responsibilities
  • Define and implement data architecture strategy and roadmap, ensuring alignment with business and IT goals.
  • Lead a team of data architects, providing mentorship, technical guidance, and career development opportunities.
  • Work closely with data science, data engineering, and analytics teams to understand their data consumption and data processing needs and make data architecture recommendations to meet their needs.
  • Engage with business, IT, and Data Strategy & Governance team to design efficient data flows: from data creation to how it flows across various systems, all the way to the points of consumption. Document these data flows using visual modeling tools.
  • Articulate the data flows to various executives and partners and make recommendations on simplifying/optimizing the overall data architecture across Amgen’s business functions.
  • Develop cost estimates, resourcing plan, timeline, value proposition, and case for implementation of these recommendations. Present the case to partners to get their consensus.
  • Design scalable, high-performance, and secure data architectures that support analytics, AI/ML, and operational workflows.
  • Stay ahead of industry trends and innovations to drive best practices in data architecture and discuss those with partners.
  • Establish enterprise-wide data modeling standards for structured, semi-structured, and unstructured data.
  • Partner with Data Strategy & Governance and Engineering teams to implement metadata management and data lineage tracking to improve data discovery and quality.
  • Collaborate with Data Strategy & Governance team on implementation of data governance policies to maintain data integrity, security, and compliance with regulations.
  • Collaborate with information security team to establish and maintain data security and privacy controls.
  • Collaborate with data stewards to manage data access controls and protect sensitive data.
  • Develop and maintain documentation on data architecture, standard processes, and policies.
  • Communicate complex data concepts to non-technical audiences effectively.
Desired Qualifications
  • Certification in cloud data architectures (AWS, Google Cloud, or Azure).
  • Experience with machine learning and AI-driven data architectures.
  • Familiarity with DevOps, CI/CD, and infrastructure-as-code (Terraform, CloudFormation).
  • Experience working with agile development methodologies such as Scaled Agile.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective therapeutic solutions and expanding its pipeline of potential new treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.